chr7-74028195-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_000501.4(ELN):c.8G>A(p.Gly3Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000168 in 1,611,348 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.000026 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000016 ( 0 hom. )
Consequence
ELN
NM_000501.4 missense
NM_000501.4 missense
Scores
1
5
13
Clinical Significance
Conservation
PhyloP100: 3.15
Genes affected
ELN (HGNC:3327): (elastin) This gene encodes a protein that is one of the two components of elastic fibers. Elastic fibers comprise part of the extracellular matrix and confer elasticity to organs and tissues including the heart, skin, lungs, ligaments, and blood vessels. The encoded protein is rich in hydrophobic amino acids such as glycine and proline, which form mobile hydrophobic regions bounded by crosslinks between lysine residues. Degradation products of the encoded protein, known as elastin-derived peptides or elastokines, bind the elastin receptor complex and other receptors and stimulate migration and proliferation of monocytes and skin fibroblasts. Elastokines can also contribute to cancer progression. Deletions and mutations in this gene are associated with supravalvular aortic stenosis (SVAS) and autosomal dominant cutis laxa. [provided by RefSeq, Aug 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.28390148).
BS2
High AC in GnomAdExome4 at 23 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ELN | NM_000501.4 | c.8G>A | p.Gly3Asp | missense_variant | 1/33 | ENST00000252034.12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ELN | ENST00000252034.12 | c.8G>A | p.Gly3Asp | missense_variant | 1/33 | 1 | NM_000501.4 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000264 AC: 4AN: 151682Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
4
AN:
151682
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000206 AC: 5AN: 243116Hom.: 0 AF XY: 0.0000226 AC XY: 3AN XY: 132864
GnomAD3 exomes
AF:
AC:
5
AN:
243116
Hom.:
AF XY:
AC XY:
3
AN XY:
132864
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000158 AC: 23AN: 1459666Hom.: 0 Cov.: 32 AF XY: 0.0000165 AC XY: 12AN XY: 726150
GnomAD4 exome
AF:
AC:
23
AN:
1459666
Hom.:
Cov.:
32
AF XY:
AC XY:
12
AN XY:
726150
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000264 AC: 4AN: 151682Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74066
GnomAD4 genome
AF:
AC:
4
AN:
151682
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
74066
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | May 29, 2019 | Has not been previously published as pathogenic or benign to our knowledge; Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect - |
Supravalvar aortic stenosis Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Sep 18, 2023 | This variant has not been reported in the literature in individuals affected with ELN-related conditions. ClinVar contains an entry for this variant (Variation ID: 1043351). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ELN protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant is present in population databases (no rsID available, gnomAD 0.01%). This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 3 of the ELN protein (p.Gly3Asp). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;.;T;T;T;.;T;.;.;.;.;T;.;.;.;.;.;.;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Benign
D;T;D;D;T;T;T;D;T;D;T;T;T;D;D;T;D;T;T;D;T
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;.;L;L;.;.;.;.;.;L;L;L;.;L;.;L;.;L;L;.;L
MutationTaster
Benign
N;N;N;N;N;N;N;N;N;N;N;N;N;N;N
PrimateAI
Uncertain
T
PROVEAN
Benign
N;.;N;N;D;N;N;D;N;N;N;N;N;N;D;D;D;N;N;D;N
REVEL
Uncertain
Sift
Pathogenic
D;.;D;D;D;D;D;D;D;.;D;D;D;D;D;D;D;.;D;D;D
Sift4G
Uncertain
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
Polyphen
P;P;P;.;.;P;.;.;P;P;P;P;P;P;.;P;.;D;P;.;.
Vest4
MutPred
Loss of glycosylation at T5 (P = 0.129);Loss of glycosylation at T5 (P = 0.129);Loss of glycosylation at T5 (P = 0.129);Loss of glycosylation at T5 (P = 0.129);Loss of glycosylation at T5 (P = 0.129);Loss of glycosylation at T5 (P = 0.129);Loss of glycosylation at T5 (P = 0.129);Loss of glycosylation at T5 (P = 0.129);Loss of glycosylation at T5 (P = 0.129);Loss of glycosylation at T5 (P = 0.129);Loss of glycosylation at T5 (P = 0.129);Loss of glycosylation at T5 (P = 0.129);Loss of glycosylation at T5 (P = 0.129);Loss of glycosylation at T5 (P = 0.129);Loss of glycosylation at T5 (P = 0.129);Loss of glycosylation at T5 (P = 0.129);Loss of glycosylation at T5 (P = 0.129);Loss of glycosylation at T5 (P = 0.129);Loss of glycosylation at T5 (P = 0.129);Loss of glycosylation at T5 (P = 0.129);Loss of glycosylation at T5 (P = 0.129);
MVP
MPC
0.24
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at